Role of transhepatic arterial radioembolization in metastatic colorectal cancer
I Bargellini, E Bozzi, G Lorenzoni, G Boni… - CardioVascular and …, 2022 - Springer
The liver represents the most frequent location of metastatic disease in colorectal cancer
(CRC). In oligometastatic disease, while surgery remains the mainstay of treatment, loco …
(CRC). In oligometastatic disease, while surgery remains the mainstay of treatment, loco …
Outcomes of hepatic artery-based therapies and systemic multiagent chemotherapy in unresectable colorectal liver metastases: a systematic review and meta …
K Sugumar, H Stitzel, V Wu, D Bajor… - Annals of surgical …, 2024 - Springer
Background Treatment of unresectable colorectal liver metastases (UCRLM) includes
locoregional and systemic therapy. A comprehensive analysis capturing long-term outcomes …
locoregional and systemic therapy. A comprehensive analysis capturing long-term outcomes …
基于循证的精准护理模式对肝癌介入患者围术期心理应激及术后并发症的影响
刘丽霞， 毛剑婷， 黄旭芳， 吴巧红 - 中华全科医学, 2022 - zhqkyx.net
目的探究基于循证的精准护理模式对肝癌介入患者围术期心理应激及术后并发症的影响.
方法丽水市中心医院介入诊疗中心自2020 年开始实施基于循证的精准护理模式, 实施前将2019 …
方法丽水市中心医院介入诊疗中心自2020 年开始实施基于循证的精准护理模式, 实施前将2019 …
Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal …
G Zhao, S Liu, Y Zhang, T Zhao, R Wang, J Bian… - Irish Journal of Medical …, 2021 - Springer
Abstract Background Callispheres® microspheres (CSM) are the first drug-eluting bead
(DEB) product developed in China; meanwhile, DEB-transarterial chemoembolization …
(DEB) product developed in China; meanwhile, DEB-transarterial chemoembolization …
Morphology, Loadability, and Releasing Profiles of CalliSpheres Microspheres in Delivering Oxaliplatin: An In Vitro Study
X Han, Q Chen, Y Sun, L Han… - Technology in Cancer …, 2019 - journals.sagepub.com
Objectives: This study aimed to explore the morphology, loadability, and releasing profiles of
CalliSpheres microspheres in delivering oxaliplatin. Methods: Varied amount (20, 40, 60 …
CalliSpheres microspheres in delivering oxaliplatin. Methods: Varied amount (20, 40, 60 …
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac] Ac-DOTA …
A Josefsson, AG Cortez, H Rajkumar… - EJNMMI …, 2023 - Springer
Background The liver is a common site for metastatic disease for a variety of cancers,
including colorectal cancer. Both primary and secondary liver tumors are supplied through …
including colorectal cancer. Both primary and secondary liver tumors are supplied through …
Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis
Y Bi, D Jiao, Y Wang, X Han, J Ren - World Journal of Surgical Oncology, 2022 - Springer
Background Drug-eluting bead transarterial chemoembolization (DEB-TACE) with
Callispheres® beads (CB) is currently used in the treatment of hepatocellular carcinoma …
Callispheres® beads (CB) is currently used in the treatment of hepatocellular carcinoma …
Liver metastases-directed therapy in the management of oligometastatic breast cancer
C Franzese, T Comito, L Viganò, V Pedicini… - Clinical Breast …, 2020 - Elsevier
Introduction In the context of metastatic breast cancer, dissemination to the liver is a frequent
occurrence. We aimed to evaluate the outcome and toxicity of metastatic breast cancer with …
occurrence. We aimed to evaluate the outcome and toxicity of metastatic breast cancer with …
Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysis
Y Ren, L Chen, S Huang, C Zhou, J Liu, Q Shi… - Abdominal …, 2020 - Springer
Purpose The purpose of this study was to evaluate the therapeutic efficacy and safety of
transarterial chemoembolization (TACE) in the treatment of patients with unresectable …
transarterial chemoembolization (TACE) in the treatment of patients with unresectable …
Transarterial chemoembolization in treatment-naïve and recurrent hepatocellular carcinoma: a propensity-matched outcome and risk signature analysis
Y Liu, Y Ren, S Ge, B Xiong, G Zhou, G Feng… - Frontiers in …, 2021 - frontiersin.org
Objectives The purpose of this study was to evaluate the efficacy and safety of transarterial
chemoembolization (TACE) in the treatment of patients with treatment-naïve hepatocellular …
chemoembolization (TACE) in the treatment of patients with treatment-naïve hepatocellular …